Complex formation of the antiviral 9-[2-(Phosphonomethoxy)ethyl]adenine (PMEA) and of its N1, N3, and N7 deaza derivatives with copper(II) in aqueous solution

Chemistry - A European Journal

Volumn 3, Issue 9, 1997, Pages 1526-1536

  Blindauer, Claudia A ^a   Emwas, Abdul H ^b   Holý, Antonín ^c   Dvořáková, Hana ^c   Sletten, Einar ^b   Sigel, Helmut ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

^b UNIVERSITY OF BERGEN   (Norway)

^c INSTITUTE OF ORGANIC CHEMISTRY AND BIOCHEMISTRY   (Czech Republic)

Author keywords

Adenine; Isomerizations; NMR spectroscopy; Nucleotides; Stability constants

Indexed keywords

EID: 0030821817     PISSN: 09476539     EISSN: None     Source Type: Journal    
DOI: 10.1002/chem.19970030922     Document Type: Article

References (78)

1. a) Probing of Nucleic Acids by Metal Ion Complexes of Small Molecules (Eds.: A. Sigel, H. Sigel), in Met. Ions Biol. Syst., Vol. 33, M. Dekker, New York, Basel, Hong Kong, 1996, pp. 1-678;
2. b) Interactions of Metal Ions with Nucleotides, Nucleic Acids, and Their Constituents (Eds.: A. Sigel, H. Sigel), in ibid., Vol. 32, 1996, pp. 1-814;
3. c) Interrelations among Metal Ions, Enzymes, and Gene Expression (Eds.: A. Sigel, H. Sigel), in ibid., Vol. 25, 1989, pp. 1-557.
4. a) Nucleotide Analogues as Antiviral Agents (Ed.: J. C. Martin), in ACS Symp. Ser., Vol. 401, American Chemical Society, Washington, DC, 1989;
5. b) P. Alexander, A. Holý, Collect. Czech. Chem. Commun. 1994, 59, 2127-2165.
6. a) C. H. Schwalbe, W. Thomson, S. Freeman, J. Chem. Soc. Perkin Trans. 1 1991, 1348-1349.
7. b) Of course, PMEA is actually more closely related to 2′-deoxy-5′-AMP or even 2′,3′-dideoxy-5′-AMP, but for these less information is available and therefore 5′-AMP is used for comparisons. With regard to the metal-ion-binding properties this does not matter, because the ribose moiety does not commonly participate in the binding of the biologically significant metal ions [3c].
8. c) H. Sigel, Chem. Soc. Reviews 1993, 22, 255-267.
9. Regarding the anti/syn conformations see: a) R. B. Martin, Y. H. Mariam, Met. Ions Biol. Syst. 1979, 8, 57-124; b) R. Tribolet, H. Sigel, Eur. J. Biochem. 1987, 163, 353-363.
10. Regarding the anti/syn conformations see: a) R. B. Martin, Y. H. Mariam, Met. Ions Biol. Syst. 1979, 8, 57-124; b) R. Tribolet, H. Sigel, Eur. J. Biochem. 1987, 163, 353-363.
11. a) R. Pauwels, J. Balzarini, D. Schols, M. Baba, J. Desmyter, I. Rosenberg, A. Holý, E. De Clercq, Antimicrob. Agents Chemother. 1988, 32, 1025-1030;
12. b) E. De Clercq, A. Holý, I. Rosenberg, ibid. 1989, 33, 185-191.
13. a) A. Merta, I. Votruba, J. Jindřich, A. Holý, I. Cihlář, I. Rosenberg, M. Otmar, T. Y. Herve, Biochem. Pharmacol. 1992, 44, 2067-2077;
14. b) S. A. Foster, J. Černý, Y.-c. Cheng, J. Biol. Chem. 1991, 266, 238-244;
15. c) J. Balzarini, E. De Clercq, ibid. 1991, 266, 8686-8689.
16. a) J. Balzarini, Z. Hao, P. Herdewijn, D. G. Johns, E. De Clercq, Proc. Natl. Acad. Sci. USA 1991, 88, 1499-1503;
17. b) J. Neyts, E. De Clercq, Biochem. Pharmacol. 1994, 47, 39-41.
18. A. S. Mildvan, Magnesium 1987, 6, 28-33.
19. L. Stryer, Biochemistry, W. H. Freeman, New York, 1988; L. Stryer, Biochemie, Spektrum, Heidelberg, Berlin, New York, 1991, p. 431.
20. L. Stryer, Biochemistry, W. H. Freeman, New York, 1988; L. Stryer, Biochemie, Spektrum, Heidelberg, Berlin, New York, 1991, p. 431.
21. H. Sigel, D. Chen, N. A. Corfù, F. Gregáň, A. Holý, M. Strašák, Helv. Chim. Acta 1992, 75, 2634-2656.
22. a) D. Chen, F. Gregáň, A. Holý, H. Sigel, Inorg. Chem. 1993, 32, 5377-5384;
23. b) D. Chen, M. Bastian, F. Gregáň, A. Holý, H. Sigel, J. Chem. Soc. Dalton Trans. 1993, 1537-1546;
24. c) M. Bastian, D. Chen, F. Gregáň, G. Liang, H. Sigel, Z. Naturforsch. 1993, 48b, 1279-1287;
25. d) B. Song, A. Holý, H. Sigel, Gazz. Chim. Ital. 1994, 124, 387-392.
26. a) H. Sigel, Coord. Chem. Rev. 1995, 144, 287-319;
27. b) H. Sigel, J. Indian Chem. Soc. (P. Ray Award Lecture) 1997, 74, 261-271.
28. a) A. Holý, E. De Clercq, I. Votruba, ACS Symp. Ser. 1989, 401, 51-71;
29. b) A. Holý, I. Votruba, A. Merta, J. Černý, J. Veselý, J. Vlach, K. Šedivá, I. Rosenberg, M. Otmar, H. Hřebabecký, M. Trávniček, V. Vonka, R. Snoeck, E. De Clercq, Antiviral Res. 1990, 13, 295-312;
30. c) A. Holý in Advances in Antiviral Drug Design, Vol. 1 (Ed.: E. De Clercq), JAI Press, Greenwich, Connecticut, USA, 1993, pp. 179-231;
31. d) for sulfur, see: D. Villemin, F. Thibault-Starzyk, Synth. Commun. 1993, 23, 1053-1059.
32. R. B. Martin, H. Sigel, Comments Inorg. Chem. 1988, 6, 285-314.
33. a) W. Kaim, J. Rall, Angew. Chem. Int. Ed. Engl. 1996, 35, 43-60;
34. b) Metalloenzymes Involving Amino Acid Residue and Related Radicals (Eds.: H. Sigel, A. Sigel), in Met. Ions Biol. Syst., Vol. 30, M. Dekker, New York, Basel, Hong Kong, 1994, pp. 1-494;
35. c) G. Berthon, Agents Actions 1993, 39, 210-217;
36. d) Electron Transfer Reactions in Metalloproteins (Eds.: H. Sigel, A. Sigel), in Met. Ions Biol. Syst., Vol. 27, M. Dekker, New York, Basel, Hong Kong, 1991, pp. 1-537.
37. C. Meiser, B. Song, E. Freisinger, M. Peilert, H. Sigel, B. Lippert, Chem. Eur. J. 1997, 3, 388-398.
38. C. A. Blindauer, A. Holý, H. Dvořáková, H. Sigel, J. Chem. Soc. Perkin Trans. 2 1997, in press.
39. a) H. Sigel, N. A. Corfù, L.-n. Ji, R. B. Martin, Comments Inorg. Chem. 1992, 13, 35-59;
40. b) L.-n. Ji, N. A. Corfù, H. Sigel, J. Chem. Soc. Dalton Trans. 1991, 1367-1375.
41. a) B. Song, D. Chen, M. Bastian, R. B. Martin, H. Sigel, Helv. Chim. Acta 1994, 77, 1738-1756;
42. b) R. K. O. Sigel, B. Song, H. Sigel, J. Am. Chem. Soc. 1997, 119, 744-755.
43. + isomer considered in ref. [22].
44. + isomer considered in ref. [22].
45. + isomer considered in ref. [22].
46. If a PA species contains the N1 atom, this is always the most basic site in the corresponding nucleobase [17] (see also footnote [b] in Table 1).
47. + systems.
48. H·PMEA·Cu = (1.05±0.13) + (0.40±0.15) = 1.45±0.20;
49. b) the average of the corresponding slopes given in ref. [20b] is very similar, i.e., m = 0.47;
50. c) M. Bastian, H. Sigel, J. Coord. Chem. 1991, 23, 137-154.
51. + as given in columns 8 and 9, respectively, of Table 2.
52. + would occur at 96% [R = 21.4; Eq. (9)];
53. b) Y. Kinjo, R. Tribolet, N. A. Corfù, H. Sigel, Inorg. Chem. 1989, 28, 1480-1489.
54. S. S. Massoud, H. Sigel, Inorg. Chem. 1988, 27, 1447-1453.
55. H. Sigel, S. S. Massoud, N. A. Corfù, J. Am. Chem. Soc. 1994, 116, 2958-2971.
56. a) G. Navon, G. Valensin. Met. Ions Biol. Syst. 1987, 21, 1-45;
57. b) E. Sletten, N. Å. Frøystein, ibid. 1996, 32, 397-418.
58. W. G. Espersen, R. B. Martin, J. Am. Chem. Soc. 1976, 98, 40-44.
59. L. G. Marzilli, Prog. Inorg. Chem. 1977, 23, 255-378.
60. N. Å. Frøystein, E. Sletten, Inorg. Chim. Acta 1987, 138, 49-53.
61. H(3d-PMEA);
62. b) R. B. Martin, Science 1963, 139, 1198-1203.
63. H. Sigel, S. S. Massoud, R. Tribolet, J. Am. Chem. Soc. 1988, 110, 6857-6865.
64. H. Sigel, Experientia 1966, 22, 497-499.
65. S. S. Massoud, H. Sigel, Eur. J. Biochem. 1989, 179, 451-458.
66. a≈ - 4.2 [36b]) in very strong acids;
67. b) R. L. Benoit, M. Fréchette, Can. J. Chem. 1984, 62, 995-1000.
68. Detailed derivations of the various equations are given in refs. [10] and (12); here they are summarized only to the extent needed to make the presented results understandable.
69. H. Sigel, B. Song, Met. Ions Biol. Syst. 1996, 32, 135-205.
70. K. Aoki, Met. Ions Biol Syst. 1996, 32, 91-134; see p. 121.
71. a) Zinc and Its Role in Biology and Nutrition (Ed.: H. Sigel), in Met. Ions Biol. Syst., Vol. 15, M. Dekker, New York, Basel, 1983, pp. 1-493;
72. b) Handbook on Metals in Clinical and Analytical Chemistry (Eds.: H. G. Seiler, A. Sigel, H. Sigel), M. Dekker, New York, Basel, Hong Kong, 1994, pp. 283-297 (Cd) and 667-674 (Zn).
73. H. Sigel, ACS Symp. Series 1989, 402, 159-204.
74. H. Sigel, Pure Appl. Chem. 1989, 61, 923-932.
75. a) H. Dvořáková, A. Holý, Collect. Czech. Chem. Commun. 1993, 58, 1419-1429;
76. b) A. Holý, I. Rosenberg, H. Dvořáková, ibid. 1989, 54, 2190-2210;
77. c) A. Holý, I. Rosenberg, ibid. 1987, 52, 2801-2809.
78. H. Sigel, A. D. Zuberbühler, O. Yamauchi, Anal. Chim. Acta 1991, 255, 63-72.